WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.), chair of the Senate Pro-Life Caucus, along with U.S. Senator Bill Cassidy, M.D. (R-LA) and others, today began an investigation into chemical abortion drug manufacturer compliance with Food and Drug Administration (FDA)-mandated safeguards associated with marketing their drugs.
